Abstract
There is increasing evidence that malignant tumor is driven by tumorinitiating cells or cancer stem cells (CSCs) have recently attracted a great number of considerations for novel cancer therapy. The concept of cancer stem cell (CSCs) is an appealing model to describe the functional heterogeneity of tumor cells. It suggests a hierarchical organization of CSCs subpopulation to sustain tumor growth and metastasis. CSCs could be resistant to standard anti-cancer drugs, which might describe the limitations of these therapies. So, much work is required to identify and use of CSCs as a target for anti-cancer treatment. This chapter focuses on the recent advances in the cancer stem cell field and anticancer drug discovery.
Related Journals
Current Drug Delivery
Current Bioactive Compounds
Current Drug Safety
Reviews on Recent Clinical Trials
Drug Delivery Letters
Recent Advances in Drug Delivery and Formulation
Recent Advances in Anti-Infective Drug Discovery
Drug Metabolism and Bioanalysis Letters
Applied Drug Research, Clinical Trials and Regulatory Affairs
Current Drug Targets - Inflammation & Allergy
Related Books
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Biopolymers In Drug Delivery: Recent Advances and Challenges
Chemoinformatics: Directions Toward Combating Neglected Diseases
Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms